Daily Summary of Health · Final editionMonday 16 November 2026 · UTC
Health News: 16 November 2026
United States loses measles-free status as CDC reports congenital measles cases
The United States lost its measles-free status after 26 years, and CDC researchers reported 112 maternal measles infections and 13 congenital measles cases from the start of 2025 through Sept. 28, 2026. The FDA approved Roche's Wilserdly for ESR1-mutated breast cancer and authorized a noninvasive ultrasound device for varicose veins. WHO warned that antimicrobial resistance is outpacing progress toward 2030 targets.
CDC reports 13 congenital measles cases and 112 maternal infections
CDC researchers reported 112 confirmed measles infections in pregnant women and 13 cases of congenital measles from the start of 2025 through Sept. 28, 2026. Six infants had measles symptoms and one had signs of meningoencephalitis. Nearly all infected women had no documented MMR vaccination before pregnancy or had an unknown history, and the report urges clinicians to prepare for maternal and infant cases.
Wegovy lowers BMI in children with obesity ages 6 to 11
In the phase III STEP Young trial, children ages 6 to 11 with obesity taking semaglutide, sold as Wegovy, had a 13.5% mean BMI decrease at week 68 versus a 2.7% increase with placebo. By week 104, mean BMI change was -9.4% with semaglutide and +8.4% with placebo. The results, published in the New England Journal of Medicine, suggest a medication option for an age group where treatment has largely been lifestyle changes.
FDA approves Roche's Wilserdly for ESR1-mutated breast cancer
The FDA on Monday approved Roche's Wilserdly, also known as giredestrant, for HR-positive, HER2-negative advanced breast cancer with an ESR1 mutation. The oral selective estrogen receptor degrader extended the time before tumor progression in the evERA trial. Roche has said the medicine could become its top-selling product ever.
FDA authorizes noninvasive ultrasound device for varicose veins
The FDA granted De Novo authorization for Theraclion's Sonovein, the first noninvasive focused ultrasound platform to treat varicose veins. The decision followed the VEINRESET trial of 70 participants, which reported a 96.8% vein occlusion rate at one year and no serious or unanticipated adverse events. The device treats reflux in great saphenous veins without incisions or catheters, a condition affecting about one third of adults.
NIAID names acting director John Powers III permanent director
NIAID named acting director John Powers III as its permanent director on Monday, ending a leadership gap that began in March 2025. The physician-scientist has worked at the institute since 1999 and has served as acting director since June. The appointment follows the ouster of director Jeanne Marrazzo and other leadership changes at the institute.
FDA approves first drug for primary membranous nephropathy
The FDA approved obinutuzumab, sold as Gazyva, for primary membranous nephropathy, the first approved drug for the rare autoimmune kidney disease. It is intended to induce remissions of proteinuria in adults at risk of progression. In the Phase III MAJESTY trial, 37% of patients on obinutuzumab achieved complete remission at two years versus 6% on tacrolimus, and 51% had complete or partial remission versus 13%.
CG Oncology bladder cancer immunotherapy cuts recurrence risk by 68%
CG Oncology announced Monday that cretostimogene, a bladder cancer immunotherapy delivered by catheter, reduced recurrence risk by 68% compared with current practice. The randomized Phase 3 study enrolled 367 patients with intermediate-risk bladder cancer, a localized form usually removed by minimally invasive surgery. The engineered common cold virus targets cells with a specific bladder tumor mutation and may change care for some patients.
A Pan American Health Organization expert group said measles has established a foothold in the United States for the first time since 2000, ending 26 years of elimination status. The country has recorded 5,739 measles cases this year, up from 2,286 in 2025, and state health departments report 10 deaths in 2026. The decision means measles is now considered endemic in the US.
Johns Hopkins finds early Alzheimer's signs in two brain regions
Johns Hopkins researchers found that the entorhinal cortex and amygdala shrink before the hippocampus in people with Alzheimer's disease, according to a study published in NeuroImage Reports. The team analyzed hundreds of MRI and PET scans from two cohorts and said the changes could appear as much as a decade before symptoms. The findings may help identify people for earlier treatment, when interventions may be most effective.
England and Wales wipe criminal records for abortion offences
Automatic pardons come into force in England and Wales, wiping criminal records for women arrested or convicted under a Victorian-era abortion law. The change will clear the names of more than 100 women and ends the criminal offence for a pregnant woman to terminate her own pregnancy at any stage. The change is intended to avoid traumatic experiences under the outdated law.
Four states end Medicaid GLP-1 weight-loss coverage, use falls 84%
A University of Pittsburgh study in JAMA found Medicaid prescriptions for weight-loss-approved GLP-1 drugs fell about 84% in four states that ended coverage on Jan. 1, 2026, compared with 10 states that kept coverage. The states were California, New Hampshire, Pennsylvania and South Carolina. The findings show state coverage decisions can quickly affect access to medicines that help regulate appetite and blood sugar.
Agent Orange exposure linked to higher Parkinson's risk in veterans
Researchers found that Vietnam-era veterans exposed to Agent Orange had a 57% greater risk of Parkinson's disease and related Lewy body dementia, according to a JAMA Neurology study of 4.9 million veterans' electronic health records. The analysis linked possible or presumed exposure to higher risk of both conditions and found direct handling or spraying was associated with a 99% higher Parkinson's risk. The findings validate veteran concerns.
Kennedy's MAHA agenda reinvigorated after Miller becomes White House chief of staff
Health secretary Robert F. Kennedy Jr.'s Make America Healthy Again agenda has been reinvigorated at the Department of Health and Human Services after Stephen Miller became White House chief of staff. Kennedy told supporters that the Senate no longer has leverage over him, less than a week after Republicans lost control of the House and Senate to Democrats.
Australian study finds pregnancy vaccines linked to lower preterm birth and stillbirth
Australian researchers found routine flu, pertussis and COVID-19 vaccines in pregnancy were associated with better birth outcomes in a study of 19,000 pregnant women. The vaccines showed no evidence of increased complication risks, while flu and pertussis shots were linked to 13% and 17% lower preterm birth risk, and pertussis to a nearly 50% lower stillbirth risk. Infants of vaccinated mothers also weighed 90 to 180 grams more on average.
Weekly CagriSema combo shows substantial weight loss in 68-week trial
In the 68-week REDEFINE 9 trial, 309 adults without diabetes received weekly CagriSema at 1.7 mg of each medicine, 1.0 mg of each medicine, or placebo. Among those who remained on treatment, average weight loss was 20.7% and 21.0% with the two CagriSema doses, versus 2.0% with placebo. An analysis including all participants found losses of 19.4%, 18.6% and 4.6%, and the authors say CagriSema remains investigational.
UK blood services issue urgent appeal for 150,000 winter donations
UK blood services have issued an urgent appeal for 150,000 donations as winter demand rises and reserves of some blood types fall to half of what is needed. The health service needs 5,000 donors a day until the new year, with blood lasting 35 days and platelets seven days. The appeal is aimed at keeping hospitals supplied for patients, including those with sickle cell disease and cancer.
Berkeley finds sleep circuit that regulates growth hormone release
Berkeley researchers identified a neural circuit that regulates growth hormone release during sleep, in a study published in Cell. By recording nerve cell activity in mice, they found that sleep promotes the hormone's secretion while growth hormone also helps regulate waking. The circuit involves cells in the hypothalamus that stimulate or inhibit the hormone's release, offering a basis for future treatments.
WHO warns antimicrobial resistance is outpacing progress toward 2030 targets
WHO officials warned that antimicrobial resistance is widespread and threatening modern medicine, though nearly nine in 10 countries now have national action plans. Progress in prevention, diagnosis and antibiotic use remains too slow for 2030 targets, with only 42 countries reporting financed, implemented and monitored plans.
In 2023, one in six laboratory-confirmed bacterial infections flagged to WHO was resistant to antibiotics used to treat it.
Ministers accused of gambling with safety over unknown NHS maternity repair costs
Ministers were accused of gambling with safety after admitting they do not know the cost of upgrading England's maternity and neonatal units. NHS chiefs said last year that 43% of such units did not meet basic safety standards. The Liberal Democrats said the government still has no figure for upgrades, even as some units are at serious risk of imminent breakdown.
Novel scents may improve memory formation in older adults
UCLA researchers found that older adults performed better on memory tasks when they encountered lavender scent during the first learning phase than during the second. Young and older adults in rooms with lavender scent did not perform significantly better than those in unscented rooms. The study, published in Frontiers in Aging Neuroscience, suggests novelty may help bind scent to experience, especially as people age.
UCLA gene boost offsets effects of autism-linked mutation in human brain cell models
UCLA Health researchers reported in Nature Neuroscience that increasing the activity of a remaining healthy gene copy can offset autism-linked mutations in human brain cell models. The team, led by Dr. Daniel Geschwind, used modified CRISPR to target enhancers for CHD8 and SCN2A genes. The early-stage work suggests a new way to address the biology behind autism and related neurodevelopmental conditions.
Cannabis use disorder linked to higher odds of suicidal thoughts
A study published by Rutgers University found that U.S. adults with cannabis use disorder had 57% higher odds of reporting suicidal thoughts than adults without the disorder. The association remained consistent from 2014 through 2023 and across age, sex and racial and ethnic groups, with women and young adults showing higher risk. Researchers said the findings apply to people with cannabis use disorder, not all cannabis users.
Low fiber can let gut bacteria feed on gut lining, Princeton studies find
Princeton researchers reported in PNAS and Nature Metabolism that plant fiber and indigestible plant proteins shape phenol metabolites made by gut bacteria. The studies, led by Jenna AbuSalim and Joshua Rabinowitz, found these proteins, called Prif, shift metabolites toward healthful phenylalanine-derived forms. Mice experiments showed that when fiber runs out, bacteria can feed on gut mucus, producing potentially harmful compounds.
NHS draft guidelines suggest sponge tests for some indigestion patients
Some people with persistent bad indigestion should be offered quick sponge tests to check for oesophageal cancer, draft NHS England guidelines recommend. The tests can be done in GP surgeries in minutes and are less invasive than hospital endoscopy checks. NICE says they can detect concerning changes in the gullet lining, though people with an all-clear result should still be monitored.
Soy foods linked with better kidney markers in Japanese diabetes study
A study of nearly 5,000 Japanese adults with type 2 diabetes found that more frequent consumption of natto, tofu and miso soup was associated with reduced kidney function less often. Higher isoflavone intake and more natto were also linked to a lower prevalence of albuminuria. Researchers say the observational findings do not establish that soy intake prevents diabetic kidney disease.
Prediabetes study examines alcohol, diet and gut bacteria patterns
Researchers in Spain examined associations between beer, wine, dietary habits and gut microbiota in adults with prediabetes. The observational analysis used data from a 12-week Moringa oleifera supplementation study and recorded diets and alcohol over three visits. It raises questions about whether the same patterns apply to men and women.
Canada's disease burden shifts toward substance use and mental health
An analysis of the Global Burden of Disease Study published in the Canadian Medical Association Journal found that cancers, cardiovascular diseases, musculoskeletal disorders and unintentional injuries caused half of Canada's health loss in 2023. The fastest-growing contributors from 2010 to 2023, after age adjustment, were substance use disorders, mental health conditions and respiratory infections, including COVID-19.
AI-designed burgers tested against Big Mac in nutrition study
Researchers at Stanford University and Stanford University School of Medicine used generative AI to create burger recipes aimed at taste, nutritional quality and environmental sustainability. The model was trained on 2,216 human-written recipes and generated one million candidates before selected ones were taste tested against a Big Mac. The study asks whether AI can help develop foods that are appealing, healthier and lower impact.